Product Pathways
BCP0021 17-DMAG
17-DMAG (Alvespimycin, KOS-1022, NSC 707545) is a potent HSP90 inhibitor with IC50 of 62 nM.
BCP0022 17AAG;Tanespimycin
17AAG is a less toxic analogue of the geldanamycin which binds to Hsp90.
BCP0032 Bortezomib
Bortezomib (PS-341, Velcade) is a potent proteasome inhibitor.
BCP0052 Elesclomol
Elesclomol (STA-4783) is a novel potent oxidative stress inducer that illicits pro-apoptosis events among tumor cells.
BCP0081 NVP-AUY922
NVP-AUY922 (VER-52296) is a highly potent HSP90 inhibitor for HSP90α and HSP90β with IC50 of 13 nM and 21 nM, respectively.
BCP0172 Butabindide oxalate
Butabindide oxalate is a selective and potent inhibitor of tripeptidyl peptidase II.
BCP0194 VX950(Telaprevir)
Telaprevir (VX-950) is an HCV NS3-4A serine protease inhibitor with IC50 of 0.35 μM.
BCP0284 VX-222
VX-222 (HCV Infection) is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
BCP0358 Daclatasvir(BMS790052)
Daclatasvir (BMS-790052) is a first-in-class, highly-selective oral HCV NS5A inhibitor.
BCP0385 17-DMAG
17-DMAG, a watersoluble geldanamycin analog belonging to the class of benzoquinones, is a selective Hsp90 inhibitor.
第一页 1 2 3 4 5 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.